| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000270062.1 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000189029 |
Resistant |
| ENSG00000270062.1 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.01102124 |
Resistant |
| ENSG00000270062.1 |
Axitinib |
Bladder urothelial carcinoma |
0.004379986 |
Sensitive |
| ENSG00000270062.1 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.0011949 |
Sensitive |
